title: Protein-nanoparticle interactions evaluation by immunomethods: Surfactants can disturb quantitative determinations.
abstract: The adsorption of proteins on nanoparticle surface is one of the first events that occur when nanoparticles enter in the blood stream, which influences nanoparticles lifetime and further biodistribution. Albumin, which is the most abundant protein in serum and which has been deeply characterized, is an interesting model protein to investigate nanoparticle-protein interactions. Therefore, the interaction of nanoparticles with serum albumin has been widely studied. Immunomethods were suggested for the investigation of adsorption isotherms because of their ease to quantify the non-adsorbed bovine serum albumin without the need of applying separation methods that could modify the balance between the adsorbed and non-adsorbed proteins. The present work revealed that this method should be applied with caution. Artifacts in the determination of free protein can be generated by the presence of surfactants such as polysorbate 80, widely used in the pharmaceutical and biomedical field, that are needed to preserve the stability of nanoparticle dispersions. It was shown that the presence of traces of polysorbate 80 in the dispersion leads to an overestimation of the amount of bovine serum albumin remaining free in the dispersion medium when determined by both radial immunodiffusion and rocket immunoelectrophoresis. However, traces of poloxamer 188 did not result in clear perturbed migrations. These methods are not appropriate to perform adsorption isotherms of proteins on nanoparticle dispersions containing traces of remaining free surfactant. They should only be applied on dispersions that are free of surfactant that is not associated with nanoparticles.
authors.affiliation: Institute of Advanced Chemistry of Catalonia IQAC-CSIC and CIBER of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), C/Jordi Girona, 18-26, Barcelona, 08034, Spain. Electronic address: cristina.fornaguera@iqac.csic.es.
authors.forename: Cristina
authors.initials: C
authors.lastname: Fornaguera
authors.affiliation: Institute of Advanced Chemistry of Catalonia IQAC-CSIC and CIBER of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), C/Jordi Girona, 18-26, Barcelona, 08034, Spain.
authors.forename: Gabriela
authors.initials: G
authors.lastname: Calderó
authors.affiliation: Institute of Advanced Chemistry of Catalonia IQAC-CSIC and CIBER of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), C/Jordi Girona, 18-26, Barcelona, 08034, Spain.
authors.forename: Conxita
authors.initials: C
authors.lastname: Solans
authors.affiliation: Université Paris Sud, Physico-chimie Pharmacotechnique Pharmacie, UMR CNRS 8612, 5 rue J.B. Clément, 92296, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Vauthier
mesh_terms: D000327:Adsorption; D003487:Cyanoacrylates / Q000737:chemistry; D004659:Enbucrilate; D007122:Immunoelectrophoresis; D019344:Lactic Acid / Q000737:chemistry; D053758:Nanoparticles / Q000737:chemistry*; D011100:Polyglycolic Acid / Q000737:chemistry; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011136:Polysorbates / Q000737:chemistry*; D012710:Serum Albumin, Bovine / Q000737:chemistry*; D012996:Solutions; D013499:Surface Properties; D013501:Surface-Active Agents / Q000737:chemistry*
chemical_list: D003487:Cyanoacrylates; D011136:Polysorbates; D012996:Solutions; D013501:Surface-Active Agents; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D012710:Serum Albumin, Bovine; D019344:Lactic Acid; D004659:Enbucrilate
keywords: Blood interaction; Immunomethods; Poloxamer 188 (PubChem CID: 24751); Poly(isobutyl-cyanoacrylate) PIBCA (PubChem CID: 14046); Poly-(lactic-co-glycolic acid) – PLGA (PubChem CID: 23111554); Polymeric nanoparticles; Polysorbate 80 (PubChem CID: 5284448); Polysorbate 80 surfactant; Protein–nanoparticle interactions